InspireMD, Inc. announced on April 8, 2025, that its Board of Directors' Compensation Committee approved inducement grants to 11 new non-executive employees. These grants totaled 299,398 shares of restricted stock, issued under InspireMD's 2024 Inducement Plan.
The grants were made as a material inducement for these individuals to join InspireMD, in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock vests over a three-year period, with one-third vesting on the first anniversary and the remainder in two equal installments.
This significant round of hiring underscores the company's continued investment in building its U.S. commercial and operational infrastructure. Expanding the team is a critical step in preparing for the anticipated U.S. launch of the CGuard Prime carotid stent system.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.